Bioverativ Revenue and Competitors
Estimated Revenue & Valuation
- Bioverativ's estimated annual revenue is currently $8.8M per year.
- Bioverativ's estimated revenue per employee is $155,000
Employee Data
- Bioverativ has 57 Employees.
- Bioverativ grew their employee count by -5% last year.
Bioverativ's People
Name | Title | Email/Phone |
---|
Bioverativ Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Bioverativ?
Bioverativ, a Sanofi company, is dedicated to transforming the lives of people with hemophilia and other rare blood disorders through world-class research, development, and commercialization of innovative therapies. We are committed to actively working with the blood disorders community, and our hemophilia therapies when launched represented the first major advancements in hemophilia treatment in more than two decades. For more information, visit www.bioverativ.com or follow @bioverativ on Twitter.
keywords:N/AN/A
Total Funding
57
Number of Employees
$8.8M
Revenue (est)
-5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $75M | 57 | 33% | N/A |
#2 | $7.4M | 57 | 0% | N/A |
#3 | $12.6M | 57 | -15% | N/A |
#4 | $7.6M | 58 | N/A | N/A |
#5 | $9.4M | 58 | 7% | N/A |